» Articles » PMID: 29128568

Colorectal Cancer Disparity in African Americans: Risk Factors and Carcinogenic Mechanisms

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2017 Nov 13
PMID 29128568
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

African Americans have the highest incidence and mortality rates of colorectal cancer (CRC) of any ethnic group in the United States. Although some of these disparities can be explained by differences in access to care, cancer screening, and other socioeconomic factors, disparities remain after adjustment for these factors. Consequently, an examination of recent advances in the understanding of ethnicity-specific factors, including genetic and environmental factors relating to risk of CRC, the biology of CRC progression, and the changes in screening and mortality, is important for evaluating our progress toward eliminating the disparities. An overarching limitation in this field is the number and sample size of studies performed to characterize the etiological bases of CRC incidence and mortality in African Americans. Despite this limitation, significant differences in etiology are manifest in many studies. These differences need validation, and their impacts on disparities need more detailed investigation. Perhaps most heartening, improvements in CRC screening can be attributed to the smallest difference in CRC incidence between African Americans and whites since the late 1980s. Cancer mortality, however, remains a persistent difference.

Citing Articles

Temporal Trends in Stomach and Colorectal Cancer Mortality by Racial Groups in Brazil (2000-2023): A Longitudinal Ecological Study.

Meira K, Guimaraes R, Guimaraes N Int J Environ Res Public Health. 2025; 22(2).

PMID: 40003434 PMC: 11855464. DOI: 10.3390/ijerph22020208.


Sleep Duration, Dietary Inflammatory Potential, and Obesity in Relation to Colorectal Cancer Incidence in the Multiethnic Cohort.

Tembo P, Zhao L, Le Marchand L, Wilkens L, Park S, Haiman C Nutrients. 2025; 17(3).

PMID: 39940229 PMC: 11820058. DOI: 10.3390/nu17030370.


Predictors of Colorectal Cancer Screening and Screening Modalities among Patients seen at Federally Qualified Health Centers Funded by the United States Health Resources and Services Administration.

Aaronson M, Pourat N, Lu C, Badiee J, Yu-Lefler H, Picillo B Prev Med Rep. 2025; 50:102976.

PMID: 39927130 PMC: 11803866. DOI: 10.1016/j.pmedr.2025.102976.


Inequalities in colorectal cancer diagnosis by ethnic group: a population-level study in the English National Health Service.

Birch R, Burr N, Taylor J, Downing A, Quirke P, Morris E BMJ Open Gastroenterol. 2025; 12(1).

PMID: 39778976 PMC: 11749721. DOI: 10.1136/bmjgast-2024-001629.


Stool and blood biomarkers for colorectal cancer management: an update on screening and disease monitoring.

Mannucci A, Goel A Mol Cancer. 2024; 23(1):259.

PMID: 39558327 PMC: 11575410. DOI: 10.1186/s12943-024-02174-w.


References
1.
OKeefe S, Li J, Lahti L, Ou J, Carbonero F, Mohammed K . Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun. 2015; 6:6342. PMC: 4415091. DOI: 10.1038/ncomms7342. View

2.
Moradi T, Delfino R, Bergstrom S, Yu E, Adami H, Yuen J . Cancer risk among Scandinavian immigrants in the US and Scandinavian residents compared with US whites, 1973-89. Eur J Cancer Prev. 1998; 7(2):117-25. View

3.
Ahmad I, Trikudanathan G, Feinn R, Anderson J, Nicholson M, Lowe S . Low Serum Vitamin D: A Surrogate Marker for Advanced Colon Adenoma?. J Clin Gastroenterol. 2016; 50(8):644-8. DOI: 10.1097/MCG.0000000000000497. View

4.
Agrawal S, Bhupinderjit A, Bhutani M, Boardman L, Nguyen C, Romero Y . Colorectal cancer in African Americans. Am J Gastroenterol. 2005; 100(3):515-23. DOI: 10.1111/j.1572-0241.2005.41829.x. View

5.
Jones B, Christensen A, Wise Sr J, Yu H . Glutathione S-transferase polymorphisms and survival in African-American and white colorectal cancer patients. Cancer Epidemiol. 2009; 33(3-4):249-56. DOI: 10.1016/j.canep.2009.08.004. View